Since consumption of calorie-dense palatable foods is highly pertinent to the onset and maintenance of obesity and diabetes, the potential modulation of taste sensitivity and food preference upon treatment with GLP-1-based therapies is of important clinical relevance. The gene discussed is GCG; the disease is diabetes mellitus.